Pacer Advisors Inc. Buys 7,153 Shares of Ventas, Inc. $VTR

Pacer Advisors Inc. increased its stake in shares of Ventas, Inc. (NYSE:VTR) by 17.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 47,772 shares of the real estate investment trust’s stock after acquiring an additional 7,153 shares during the period. Pacer Advisors Inc.’s holdings in Ventas were worth $3,697,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Bridgewater Advisors Inc. increased its holdings in Ventas by 2.0% during the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after purchasing an additional 133 shares in the last quarter. IHT Wealth Management LLC lifted its holdings in shares of Ventas by 3.2% in the fourth quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after purchasing an additional 137 shares in the last quarter. True Wealth Design LLC boosted its position in shares of Ventas by 32.0% during the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock worth $44,000 after buying an additional 138 shares during the period. Cigna Investments Inc. New boosted its position in shares of Ventas by 3.3% during the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after buying an additional 142 shares during the period. Finally, Parallel Advisors LLC boosted its position in shares of Ventas by 4.6% during the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after buying an additional 175 shares during the period. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Ventas Stock Performance

VTR opened at $82.90 on Tuesday. The business’s 50-day simple moving average is $85.02 and its 200 day simple moving average is $82.61. Ventas, Inc. has a 52-week low of $61.76 and a 52-week high of $91.06. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The firm has a market capitalization of $40.30 billion, a PE ratio of 150.73, a PEG ratio of 1.75 and a beta of 0.71.

Ventas (NYSE:VTR) last posted its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The firm’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, sell-side analysts expect that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Ventas’s dividend payout ratio (DPR) is currently 378.18%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on VTR shares. Evercore reissued an “outperform” rating and issued a $95.00 target price on shares of Ventas in a research report on Wednesday, April 29th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Ventas in a research report on Friday, March 27th. KeyCorp raised their price target on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Raymond James Financial started coverage on shares of Ventas in a report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 price objective on the stock. Finally, Citigroup boosted their price objective on shares of Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Fifteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $96.00.

Insider Buying and Selling at Ventas

In other news, Director Michael J. Embler bought 2,500 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the transaction, the director owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by company insiders.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.